In Vitro Resistance Profile of the Hepatitis C Virus NS3/4A Protease Inhibitor TMC435

TMC435 is a small-molecule inhibitor of the NS3/4A serine protease of hepatitis C virus (HCV) currently in phase 2 development. The in vitro resistance profile of TMC435 was characterized by selection experiments with HCV genotype 1 replicon cells and the genotype 2a JFH-1 system. In 80% (86/109) of...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Lenz, Oliver, Verbinnen, Thierry, Lin, Tse-I, Vijgen, Leen, Cummings, Maxwell D., Lindberg, Jimmy, Berke, Jan Martin, Dehertogh, Pascale, Fransen, Els, Scholliers, Annick, Vermeiren, Katrien, Ivens, Tania, Raboisson, Pierre, Edlund, Michael, Storm, Susan, Vrang, Lotta, de Kock, Herman, Fanning, Gregory C., Simmen, Kenneth A.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society for Microbiology (ASM) 2010
Aiheet:
Antiviral Agents
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2863659/
https://ncbi.nlm.nih.gov/pubmed/20176898
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01452-09
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia